BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 21696985)

  • 21. Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease.
    Reimann MJ; Cremer S; Christiansen L; Ibragimov E; Gao F; Cirera S; Fredholm M; Olsen LH; Karlskov-Mortensen P
    Mamm Genome; 2024 Mar; 35(1):77-89. PubMed ID: 37938355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urine 5-hydroxyindoleacetic acid in Cavalier King Charles spaniels with preclinical myxomatous mitral valve disease.
    Christiansen LB; Cremer SE; Helander A; Madsen T; Reimann MJ; Møller JE; Höglund K; Ljungvall I; Häggström J; Olsen LH
    Vet J; 2019 Aug; 250():36-43. PubMed ID: 31383418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular twist and circumferential strain in dogs with myxomatous mitral valve disease.
    Zois NE; Olsen NT; Moesgaard SG; Rasmussen CE; Falk T; Häggström J; Pedersen HD; Møller JE; Olsen LH
    J Vet Intern Med; 2013; 27(4):875-83. PubMed ID: 23731222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.
    Ljungvall I; Rajamäki MM; Crosara S; Olsen LH; Kvart C; Borgarelli M; Höglund K; Häggström J
    Am J Vet Res; 2011 Aug; 72(8):1022-8. PubMed ID: 21801058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
    Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
    J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
    Lu CC; Liu MM; Culshaw G; French A; Corcoran B
    J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for coughing in dogs with naturally acquired myxomatous mitral valve disease.
    Ferasin L; Crews L; Biller DS; Lamb KE; Borgarelli M
    J Vet Intern Med; 2013; 27(2):286-92. PubMed ID: 23398050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
    Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
    J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
    Häggström J; Hansson K; Kvart C; Karlberg BE; Vuolteenaho O; Olsson K
    Am J Vet Res; 1997 Jan; 58(1):77-82. PubMed ID: 8989501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left atrial volume and function in dogs with naturally occurring myxomatous mitral valve disease.
    Höllmer M; Willesen JL; Tolver A; Koch J
    J Vet Cardiol; 2017 Feb; 19(1):24-34. PubMed ID: 27825670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
    Ljungvall I; Höglund K; Lilliehöök I; Oyama MA; Tidholm A; Tvedten H; Häggström J
    J Vet Intern Med; 2013; 27(5):1105-12. PubMed ID: 23865457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue Doppler and strain imaging in dogs with myxomatous mitral valve disease in different stages of congestive heart failure.
    Tidholm A; Ljungvall I; Höglund K; Westling AB; Häggström J
    J Vet Intern Med; 2009; 23(6):1197-207. PubMed ID: 19909428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases.
    de Andrade JN; Christopher Orton E; Boon J; Nishimori CT; Olivaes C; Camacho AA
    J Vet Cardiol; 2011 Sep; 13(3):197-201. PubMed ID: 21824833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease.
    Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Elliott J
    Am J Vet Res; 2012 Nov; 73(11):1765-74. PubMed ID: 23106462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biopterin status in dogs with myxomatous mitral valve disease is associated with disease severity and cardiovascular risk factors.
    Reimann MJ; Häggström J; Mortensen A; Lykkesfeldt J; Møller JE; Falk T; Olsen LH
    J Vet Intern Med; 2014; 28(5):1520-6. PubMed ID: 25274442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J; Gerlach N; Weber K; Klima A; Wess G
    Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease.
    Dickson D; Caivano D; Matos JN; Summerfield N; Rishniw M
    J Vet Cardiol; 2017 Dec; 19(6):469-479. PubMed ID: 29111284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tricuspid annular plane systolic excursion in dogs with myxomatous mitral valve disease with and without pulmonary hypertension.
    Poser H; Berlanda M; Monacolli M; Contiero B; Coltro A; Guglielmini C
    J Vet Cardiol; 2017 Jun; 19(3):228-239. PubMed ID: 28579307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cytokines and hormones in dogs before and after treatment of diabetic ketoacidosis and in uncomplicated diabetes mellitus.
    O'Neill S; Drobatz K; Satyaraj E; Hess R
    Vet Immunol Immunopathol; 2012 Aug; 148(3-4):276-83. PubMed ID: 22840590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left atrial deformation and phasic function determined by two-dimensional speckle-tracking echocardiography in dogs with myxomatous mitral valve disease.
    Caivano D; Rishniw M; Birettoni F; Patata V; Giorgi ME; Porciello F
    J Vet Cardiol; 2018 Apr; 20(2):102-114. PubMed ID: 29459124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.